https://www.wsj.com/articles/fda-seeks-more-data-on-lillys-alzheimers-drug-candidate-11674172480
0
0
1/20/23 at 5:08pm
Organization
The Wall Street Journal
Author
Peter Loftus
30 words
0
Comments
Setback could delay potential commercial introduction of drug called donanemab by at least several months
You are the first to view
Create an account
or login to join the discussion